Biotransformation

About

Biotransformation refers to the chemical modification of compounds — particularly drugs or xenobiotics — by biological systems, most commonly through enzymatic processes in living organisms. In this context, it describes how the body metabolizes substances, converting them into metabolites via pathways such as oxidation, reduction, hydrolysis, or conjugation. In drug discovery and development, understanding biotransformation is critical for identifying how candidate compounds are processed physiologically, which metabolites are produced, and what metabolic pathways are involved. Robotics and automation play an increasingly important role here: high-throughput screening platforms, combinatorial chemistry pipelines, and specialized automated systems for measuring low-level radioactivity enable researchers to rapidly profile metabolite identification studies at scale. This matters because biotransformation data directly informs drug safety, efficacy, and dosing decisions — poorly metabolized compounds or toxic metabolites can disqualify drug candidates early. By integrating robotic automation into biotransformation workflows, researchers can process far more compounds faster, reducing costs and accelerating the path from initial discovery toward viable therapeutics.